Atorvastatin lowers inflammatory sputum mediators in smokers with asthma

Catherine Charron (London, United Kingdom), Catherine Charron, Rekha Chaudhuri, Mark Spears, Kazuhiro Ito, Charles McSharry, Neil Thomson

Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Session: Novel treatments for cough, asthma, COPD and bronchiectasis
Session type: Thematic Poster Session
Number: 3953
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Catherine Charron (London, United Kingdom), Catherine Charron, Rekha Chaudhuri, Mark Spears, Kazuhiro Ito, Charles McSharry, Neil Thomson. Atorvastatin lowers inflammatory sputum mediators in smokers with asthma. Eur Respir J 2015; 46: Suppl. 59, 3953

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015

Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013

Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013


Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Various biomarkers of oxidative stress in patients with uncontrolled asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Biomarkers in COPD- The role of resistin and leptin
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015

Induced sputum supernatant eicosanoids during oral aspirin challenge of asthmatic patients with and without aspirin hypersensitivity and healthy controls
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
Source: Eur Respir J 2007; 30: 472-478
Year: 2007



Sputum biomarkers of inflammation in smokers and subjects with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Exhaled particles as markers of small airways inflammation in asthmatic subjects
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015